- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06769282
Trauma-Informed Peer Aggression and Dating Violence Prevention for Preteens Receiving Intensive Mental Health Services (SPARE)
Cross-Cutting Trauma-Informed Peer Aggression and Dating Violence Prevention for Preteens Receiving Intensive Mental Health Services
The goal of this clinical trial is to learn if this intervention (Social Skills, Problem Solving, emotion Regulation, and psycho-Education on Trauma: A Trauma-Informed Peer Aggression and Teen Dating Violence Prevention Program; SPARE) can treat peer aggression and prevent teen dating violence in preteens receiving intensive mental health services. The main questions it aims to answer are:
- Does receiving SPARE reduce proactive and reactive aggression at post-intervention and 3- and 9-month follow-ups?
- Does receiving SPARE reduce positive attitude about TDV, prevent TDV behaviors, and improve mental health outcomes at post-intervention and 3- and 9-month follow-ups?
Researchers will compare youth receiving SPARE to youth receiving treatment as usual to see if SPARE results in improved proactive and reactive aggression, TDV attitudes and behaviors, and mental health outcomes.
Participants will:
- Receive SPARE via group therapy incorporated into their daily programing at an intensive mental health program
- Complete study questionnaires at program intake and discharge as well as at 3-month and 9-month follow-up assessments
Study Overview
Status
Conditions
Detailed Description
SPARE will include 5 components: (1) Social skills training, including selecting healthy friends and partners, (2) Problem solving with emphasis on positive outcomes of nonaggressive solutions, (3) Awareness of domineering behavior and conflict resolution skills, (4) emotion Regulation, and (5) psycho-Education on ACEs and trauma. SPARE is group-based each of the 5 treatment components are designed to be delivered in two 45-minute sessions per week (see Table 3), for a total of 10 sessions. Each session will include 30 minutes of didactic instruction on the component with developmentally engaging activities to illustrate concepts and an individually tailored 15-minute narrative and mindfulness activity, which may address a traumatic memory depending on youth need and receptivity. SPARE will be delivered by the PI and will replace a social skills group twice a week at CP when it is implemented.
SPARE will be implemented in two sites of a child partial hospitalization program (A & B). Both sites CP serve youth 7-13 years old who (1) require services more intensive than outpatient care or (2) are transitioning from higher care (e.g., inpatient). Youth attend CP for 6 hours a day Monday through Friday. The modal length of stay for youth is 7 weeks. To minimize disruptions in CP care, SPARE will be implemented continuously at one site for 6 months (Active Phase) while TAU data is collected from the other site. After 6 months, conditions at each site will flip, resulting in approximately 5 cohorts of SPARE per site (n=88). Sites A and B will be randomly assigned using yoked randomization to Active Phase or TAU first. During Active Phase, all youth ≥11 years will receive SPARE two days per week (regardless of research eligibility).
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Elizabeth C Tampke, Ph.D.
- Phone Number: (401) 793-8351
- Email: elizabeth_tampke@brown.edu
Study Locations
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02906
- Recruiting
- Rhode Island Hospital
-
Contact:
- Elizabeth C Tampke, PhD
- Phone Number: (401) 793-8351
- Email: elizabeth_tampke@brown.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- (1) aged 11-13 years
- (2) enrolled in CP,
- (3) ability to write and speak in English
- (4) parent/guardian consent.
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention (SPARE) plus Treatment as Usual
Participants assigned to this arm will receive SPARE in the form of group therapy in addition to treatment as usual at a child partial program.
|
5 components: (1) Social skills training, including selecting healthy friends and partners, (2) Problem solving with emphasis on positive outcomes of nonaggressive solutions, (3) Awareness of domineering behavior in self and conflict resolution skills, (4) emotion Regulation, and (5) psycho-education on ACEs and trauma.
Each session will include 30 minutes of didactic instruction on the component with developmentally engaging activities to illustrate concepts and an individually tailored 15-minute narrative and mindfulness activity, which may address a traumatic memory depending on youth need and receptivity.
Other Names:
|
|
Active Comparator: Treatment As Usual
Arm Description: Participants assigned to this arm will receive treatment as usual at a child partial program.
|
Treatment As Usual consists of individual, family, occupational, and art therapy, social skills and emotion regulation groups, and therapeutic milieu.
All staff and clinicians are trained in the Incredible Years Parenting Program, which aims reduce behavioral problems, enhance children's social and emotional competence, and improve child-parent interactions.
Children also receive individualized treatment tailored for their needs (e.g., sleep interventions).
Behavioral health needs staff (BHS) facilitate children's skill acquisition and generalization, implement individualized behavior contingency programs, and assist caregivers with parenting strategies via daily check-ins
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proactive and Reactive Aggression Questionnaire (PRA)
Time Frame: Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
6 items; 2 subscales to assess proactive and reactive aggression; preteen self-report and parent-report
|
Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptance of Couple Violence (ACV)
Time Frame: Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
11 items; 2 subscales that assess acceptance of male-to-female violence and female to male violence; preteen self-report
|
Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
|
Conflict in Adolescent Dating and Relationship Inventory (CADRI)
Time Frame: Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
35 items; 5 subscales that assess physical abuse, relational abuse, sexual abuse, threatening behavior, verbal-emotional
|
Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
|
Digital Relationship Behaviors (DRB)
Time Frame: Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
32 items; 4 subscales assessing victimization and perpetration of Threatening/Coercive Behavior and Monitoring Behavior
|
Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
|
Children's Depression inventory (CDI-2)
Time Frame: Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
28 items for self-report; 17 items for parent report; Depression measure; preteen self-report; parent report
|
Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
|
Screen for Child Anxiety Related Emotional Disorders (SCARED)
Time Frame: Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
41 items; 4 subscales that assess anxiety symptoms related to panic/somatic, generalized anxiety, separation, social, and school avoidance
|
Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
|
Disruptive Behavior Disorders Scale
Time Frame: Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
42 items; 4 subscales assessing symptoms of ADHD-Inattention, ADHD-Hyperactivity/Impulsivity, Conduct Disorder, and Oppositional Defiant Disorder; parent report
|
Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
|
ABCD Substance Use Screener
Time Frame: Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
10 items; 3 subscales assessing use of alcohol, tobacco, and marijuana; child report
|
Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PROMIS Peer Relations-Short Form
Time Frame: Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
8 items; 2 subscales assessing friendship quality and peer acceptance; preteen report; caregiver report
|
Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
|
Problem-Solving Measure for Conflict (PSM-C).
Time Frame: Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
6 items; Assesses problem solving skills, Child report
|
Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
|
Conflict Resolution Style Inventory (CRSI)
Time Frame: Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
20 items; 5 subscales assessing styles of Competing, Avoiding, Accommodating, Compromising, and Collaborating; preteen report
|
Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
|
Children's Emotion Management Scale (CEMS)
Time Frame: Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
33 items; 3 subscales assessing emotion regulation of anger, sadness, and worry; Child and parent report
|
Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
|
Child and Adolescent Trauma Screen (CATS)
Time Frame: Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
40 items; 3 subscales assessing occurrence of potential traumatic event, trauma symptoms, and symptom impairment; child and parent report.
|
Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
|
Domineering Awareness Questionnaire (AAQ)
Time Frame: Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
10 items; Assesses awareness of domineering behavior and aggression; child report
|
Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
|
ACEs Knowledge Questionnaire (AKQ)
Time Frame: Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
10 items; Assesses knowledge of the impact on ACEs on relationships; child-report
|
Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
|
Pubertal Development Scale (PDS)
Time Frame: Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
5 items for boys; 6 items for girls; Assesses stage of pubertal development and onset of menarche (girls); child report
|
Baseline, Termination of treatment at the child partial program (average of 7 weeks post-baseline), 3-month follow up, 9-month follow up
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Elizabeth C Tampke, PhD, Rhode Island Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- K01CE003687 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Teen Dating Violence
-
Centers for Disease Control and PreventionBaltimore City Health Department; NORC at the University of Chicago; Ogilvy Public... and other collaboratorsCompletedTeen Dating Violence | Healthy Dating Relationship BehaviorsUnited States
-
The University of Texas Health Science Center,...Centers for Disease Control and Prevention; Injury Control Research Centers...Not yet recruitingBullying | Teen Dating ViolenceUnited States
-
University of MichiganNational Institute of Mental Health (NIMH)RecruitingDepression | Anxiety | Drug Use | Racial Disparities | Minority Stress | Family Relationships | LGBTQ | Teen Dating Violence | Sexual Risk ReductionUnited States
-
Boston UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Completed
-
Eskisehir Osmangazi UniversityNot yet recruiting
-
Gazi UniversityMersin University; Tarsus UniversityNot yet recruiting
-
Western University, CanadaRecruitingAdolescent Behavior | Dating ViolenceCanada
-
The University of Texas Health Science Center,...Centers for Disease Control and Prevention; Rhode Island Hospital; Sam Houston... and other collaboratorsActive, not recruitingDating Violence | Firearm Injury and ViolenceUnited States
-
Rhode Island HospitalCompletedAdolescent Dating ViolenceUnited States
-
Istanbul University - CerrahpasaCompletedIntimate Partner Violence | Dating Violence | Nursing Students | Bystander EffectTurkey
Clinical Trials on Experimental: Intervention (SPARE) plus Treatment as Usual
-
South London and Maudsley NHS Foundation TrustCompletedAttention Deficit Hyperactivity DisorderUnited Kingdom
-
Centre for Addiction and Mental HealthCompleted
-
Pakistan Institute of Living and LearningCompletedMaternal DepressionPakistan
-
University of IndianapolisUniversity of Missouri, Kansas City; Missouri State UniversityCompletedHypertension | Diabete Type 2United States
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)Completed
-
Nova Scotia Health AuthorityCompletedEating DisordersCanada
-
Yale UniversityNational Institute on Drug Abuse (NIDA)Completed
-
Chang Gung Memorial HospitalMinistry of Science and Technology, TaiwanCompleted
-
Hospital Universitari Vall d'Hebron Research InstituteEuropean CommissionRecruitingObesity, MorbidSpain
-
Vapotherm, Inc.Knox Community Hospital; Riverside Regional Medical Center; Midwest Chest ConsultantsCompleted